A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

A new type of PrEP injection, requiring only three injections a year, could be on the way. The FDA approved injections of cabotegravir in 2021 as a form of PrEP, to minimize the risk of acquiring HIV.

Study participants who were at least 30 years old, injected heroin, or had been in prison were more likely than participants without these characteristics to choose pre-exposure prophylaxis (PrEP) for ...

According to ABC News' latest report, almost 38,000 Americans are diagnosed with HIV (human immunodeficiency virus) every year. There are already treatments to prevent HIV infection. In 2012, the Food ...

An injection given every two months found to be very effective in preventing HIV transmission, claims a new study. Currently, there are nearly 1.1 million individuals living with HIV in the U.S. The ...

More encouraging news has been announced about the new, twice-yearly PrEP injection currently undergoing trials. Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BRISBANE, Australia – When given a choice for pre-exposure ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

An injectable form of PrEP has been given “breakthrough therapy” designation by the FDA. PrEP, or pre-exposure prophylaxis, uses antiretroviral therapies designed to combat HIV to help prevent ...

A study suggests that a new medication – taken as an injection every two months – could be more effective at preventing HIV transmissions than Truvada. Truvada was the first medication approved by the ...

A long-awaited development to help stop the spread of HIV and AIDS was approved by the U.S. Food and Drug Administration this week, and scientists are calling it a game-changer. The drug, called ...